Boston, Massachusetts
Associate Professor of Surgery
Harvard Medical School
Co-Director, Endovascular Surgery
Brigham and Women's Hospital
SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2024
Session Moderator
SESSION-30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Presenter
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
New Subanalysis Findings From The BEST-CLI RCT Are Critically Important To The Treatment Of CLTI Patients: Open Surgical Bypass Operations Still Have A Critical Role: Open Versus Endo Treatment Of Infrapopliteal Disease: Does Endo Treatment Burn Bridges
3:58 PM - 4:03 PM
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Why PTFE Bypasses To Infrapopliteal Arteries Have Been A Controversial Procedure For More Than 40 Years – And Why They Continue To Be
1:18 PM - 1:23 PM
Thursday, November 21, 2024
Presenter
SESSION 59: NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28) AND MANAGEMENT OF PERIGRAFT SEROMAS
PTFE Bypasses To Infrapopliteal Targets Can Be Worthwhile For Limb Salvage In Patients With End Stage CLTI: When Is This So And Technical Tips To Make Them Work
1:18 PM - 1:23 PM
 
previous next